Use of Palliative Care, Oxygen Therapy Increasing for COPD

Share this content:
Use of Palliative Care, Oxygen Therapy Increasing for COPD
Use of Palliative Care, Oxygen Therapy Increasing for COPD

MONDAY, July 2, 2018 (HealthDay News) -- For patients with advanced chronic obstructive pulmonary disease (COPD), the use of formal palliative care services and long-term oxygen therapy has increased but remains low, according to a study published online June 11 in the American Journal of Respiratory and Critical Care Medicine.

Andrea S. Gershon, M.D., from Sunnybrook Health Sciences Centre in Toronto, and colleagues described trends in use of end-of-life care strategies by people with advanced COPD. The annual proportions of individuals who received formal palliative care, long-term oxygen therapy, or opioids from 2004 to 2014 were ascertained.

A total of 151,912 individuals with advanced COPD were identified in Ontario between 2004 and 2014. The researchers found that there was a 1 percent increase per year in the use of formal palliative care services, from 5.3 percent in 2004 to 14.3 percent in 2014 (P for trend < 0.001); use of long-term oxygen therapy increased 1.1 percent per year, from 26.4 percent in 2004 to 35.3 percent in 2013 (P for trend < 0.001). Opioid use remained stable (40 percent in 2004 and 41.8 percent in 2014; P for trend = 0.08). The likelihood of using formal palliative care services and long-term oxygen therapy was lower among younger individuals.

"Efforts should focus on increasing access to such strategies as well as educating patients and providers of their benefits," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Increase Seen in Salmonella Illnesses From Ground Beef

CDC: Increase Seen in <i>Salmonella</i> Illnesses From Ground ...

246 people now sickened; 59 people have been hospitalized; no deaths reported to date

Epinephrine Personal Autoinjectors Cost-Effective at 24

Epinephrine Personal Autoinjectors Cost-Effective at &#36;24

Based on 10-fold fatality risk difference, value-based price for personal epinephrine $24

Burden of Liver Cancer Rising in Medicare Patients

Burden of Liver Cancer Rising in Medicare Patients

Coexistence of other liver conditions tied to even higher risk for death, health care costs

is free, fast, and customized just for you!




Already a member?

Sign In Now »